Selected research
Industry Research
Ceftiofur Industry Research Report 2026
Market perspective
The global Ceftiofur market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ceftiofur is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ceftiofur is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ceftiofur is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ceftiofur include Ceva Sant Animale, HIPRA, Norbrook Laboratories, Orchid Chemicals & Pharmaceuticals, Shangdong Fumeile, Pfizer, Qilu Pharmaceutical and Shandong Jiulong Hisince Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ceftiofur market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ceftiofur Market by Company
Ceva Sant Animale
HIPRA
Norbrook Laboratories
Orchid Chemicals & Pharmaceuticals
Shangdong Fumeile
Pfizer
Qilu Pharmaceutical
Shandong Jiulong Hisince Pharmaceutical
Ceftiofur Segment by Type
Ceftiofur Sodium
Ceftiofur Hydrochloride
Others
Ceftiofur Segment by Application
Bovine Interdigital Necrobacillosis
Urinary Tract Infections
Respiratory Infections
Others
Ceftiofur Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceftiofur market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ceftiofur and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceftiofur.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ceftiofur manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ceftiofur by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ceftiofur in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ceftiofur Sodium
- Ceftiofur Hydrochloride
- Others
Applications
- Bovine Interdigital Necrobacillosis
- Urinary Tract Infections
- Respiratory Infections
- Others
Companies covered
- Ceva Sant Animale
- HIPRA
- Norbrook Laboratories
- Orchid Chemicals & Pharmaceuticals
- Shangdong Fumeile
- Pfizer
- Qilu Pharmaceutical
- Shandong Jiulong Hisince Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ceftiofur Market Size (2021-2032)
- 2.2.2 Global Ceftiofur Sales (2021-2032)
- 2.2.3 Global Ceftiofur Market Average Price (2021-2032)
- 2.3 Ceftiofur by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Ceftiofur Sodium
- 2.3.3 Ceftiofur Hydrochloride
- 2.3.4 Others
- 2.4 Ceftiofur by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Bovine Interdigital Necrobacillosis
- 2.4.3 Urinary Tract Infections
- 2.4.4 Respiratory Infections
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ceftiofur Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ceftiofur Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Ceftiofur Revenue of Manufacturers (2021-2026)
- 3.4 Global Ceftiofur Average Price by Manufacturers (2021-2026)
- 3.5 Global Ceftiofur Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ceftiofur, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ceftiofur, Product Type & Application
- 3.8 Global Manufacturers of Ceftiofur, Established Date
- 3.9 Global Ceftiofur Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ceva Sant Animale
- 4.1.1 Ceva Sant Animale Company Information
- 4.1.2 Ceva Sant Animale Business Overview
- 4.1.3 Ceva Sant Animale Ceftiofur Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Ceva Sant Animale Ceftiofur Product Portfolio
- 4.1.5 Ceva Sant Animale Recent Developments
- 4.2 HIPRA
- 4.2.1 HIPRA Company Information
- 4.2.2 HIPRA Business Overview
- 4.2.3 HIPRA Ceftiofur Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 HIPRA Ceftiofur Product Portfolio
- 4.2.5 HIPRA Recent Developments
- 4.3 Norbrook Laboratories
- 4.3.1 Norbrook Laboratories Company Information
- 4.3.2 Norbrook Laboratories Business Overview
- 4.3.3 Norbrook Laboratories Ceftiofur Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Norbrook Laboratories Ceftiofur Product Portfolio
- 4.3.5 Norbrook Laboratories Recent Developments
- 4.4 Orchid Chemicals & Pharmaceuticals
- 4.4.1 Orchid Chemicals & Pharmaceuticals Company Information
- 4.4.2 Orchid Chemicals & Pharmaceuticals Business Overview
- 4.4.3 Orchid Chemicals & Pharmaceuticals Ceftiofur Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Orchid Chemicals & Pharmaceuticals Ceftiofur Product Portfolio
- 4.4.5 Orchid Chemicals & Pharmaceuticals Recent Developments
- 4.5 Shangdong Fumeile
- 4.5.1 Shangdong Fumeile Company Information
- 4.5.2 Shangdong Fumeile Business Overview
- 4.5.3 Shangdong Fumeile Ceftiofur Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shangdong Fumeile Ceftiofur Product Portfolio
- 4.5.5 Shangdong Fumeile Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Ceftiofur Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Ceftiofur Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Qilu Pharmaceutical
- 4.7.1 Qilu Pharmaceutical Company Information
- 4.7.2 Qilu Pharmaceutical Business Overview
- 4.7.3 Qilu Pharmaceutical Ceftiofur Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Qilu Pharmaceutical Ceftiofur Product Portfolio
- 4.7.5 Qilu Pharmaceutical Recent Developments
- 4.8 Shandong Jiulong Hisince Pharmaceutical
- 4.8.1 Shandong Jiulong Hisince Pharmaceutical Company Information
- 4.8.2 Shandong Jiulong Hisince Pharmaceutical Business Overview
- 4.8.3 Shandong Jiulong Hisince Pharmaceutical Ceftiofur Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shandong Jiulong Hisince Pharmaceutical Ceftiofur Product Portfolio
- 4.8.5 Shandong Jiulong Hisince Pharmaceutical Recent Developments
5 Global Ceftiofur Market Scenario by Region
- 5.1 Global Ceftiofur Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ceftiofur Sales by Region: 2021-2032
- 5.2.1 Global Ceftiofur Sales by Region: 2021-2026
- 5.2.2 Global Ceftiofur Sales by Region: 2027-2032
- 5.3 Global Ceftiofur Revenue by Region: 2021-2032
- 5.3.1 Global Ceftiofur Revenue by Region: 2021-2026
- 5.3.2 Global Ceftiofur Revenue by Region: 2027-2032
- 5.4 North America Ceftiofur Market Facts & Figures by Country
- 5.4.1 North America Ceftiofur Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ceftiofur Sales by Country (2021-2032)
- 5.4.3 North America Ceftiofur Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Ceftiofur Market Facts & Figures by Country
- 5.5.1 Europe Ceftiofur Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ceftiofur Sales by Country (2021-2032)
- 5.5.3 Europe Ceftiofur Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Ceftiofur Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ceftiofur Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ceftiofur Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ceftiofur Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ceftiofur Market Facts & Figures by Country
- 5.7.1 South America Ceftiofur Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ceftiofur Sales by Country (2021-2032)
- 5.7.3 South America Ceftiofur Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Ceftiofur Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ceftiofur Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ceftiofur Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ceftiofur Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Ceftiofur Sales by Type (2021-2032)
- 6.1.1 Global Ceftiofur Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Ceftiofur Sales Market Share by Type (2021-2032)
- 6.2 Global Ceftiofur Revenue by Type (2021-2032)
- 6.2.1 Global Ceftiofur Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ceftiofur Revenue Market Share by Type (2021-2032)
- 6.3 Global Ceftiofur Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ceftiofur Sales by Application (2021-2032)
- 7.1.1 Global Ceftiofur Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Ceftiofur Sales Market Share by Application (2021-2032)
- 7.2 Global Ceftiofur Revenue by Application (2021-2032)
- 7.2.1 Global Ceftiofur Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ceftiofur Revenue Market Share by Application (2021-2032)
- 7.3 Global Ceftiofur Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ceftiofur Value Chain Analysis
- 8.1.1 Ceftiofur Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ceftiofur Production Mode & Process
- 8.2 Ceftiofur Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ceftiofur Distributors
- 8.2.3 Ceftiofur Customers
9 Global Ceftiofur Analyzing Market Dynamics
- 9.1 Ceftiofur Industry Trends
- 9.2 Ceftiofur Industry Drivers
- 9.3 Ceftiofur Industry Opportunities and Challenges
- 9.4 Ceftiofur Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst